The program has been recognized by the American Diabetes Association (ADA) since 1993. The ADA endorses the National Standards for Diabetes Self-Management Education to promote quality education for people with diabetes.
Living with diabetes can be very challenging. The outstanding interdisciplinary team share a commitment to helping you live life to the fullest. The team includes highly experienced diabetes specialists, nurse practitioners, certified diabetes educators (including nurses, pharmacists, and dietitians), and other specialists skilled in treating the complex needs of diabetes patients. The coordinated care approach keeps the focus on the patient and allows for personalization of medication, monitoring, lifestyle changes, and nutrition education. Adults with type 1 diabetes or type 2 diabetes that is newly diagnosed, difficult to manage, or in need of long-term monitoring and follow-up, will receive comprehensive care at BMC.
Contact Us
2nd Floor
Preston Family Building 617.638.7470
Monday-Friday - 7:30 AM - 5:30 PM
Specialty Clinics
Endocrinology
Treatments & Services
Our Team
Diabetes Doctors
Kathryn L Fantasia, MD, MSc
Shirin Haddady, MD, MPH
Katherine L. Modzelewski, MD
Ivania M. Rizo, MD
Devin W. Steenkamp, MBChB
Catherine A. Sullivan, MD
Patient Resources
Diabetes Resource Center
Quick Help
Diabetes Self-Management Education Program
Our Diabetes Self-Management (DSM) Education Program can provide you with the knowledge and skills you need to keep yourself as healthy as possible. We are here to help support behavioral changes, improve your general health, and reduce your risk of diabetes complications.
Read Our Guide
There's a lot of information to keep track of and skills to learn when you're living with diabetes, but BMC here to help. We have assembled a booklet to help you manage your diabetes, live an active life, and stay healthy. Inside, you'll find information on all aspects of caring for yourself, from healthy eating to managing stress to monitoring blood sugar.
Our booklet is also available in: Español | Kreyòl Ayisyen | Português | Tiếng Việt
BMC offers a full range of diabetes care, including nutrition, podiatry, ophthalmology, cardiology, dental services, and more. This resource center is here to answer basic questions and to help you understand and manage your health. It’s not a replacement for your care team, but a resource you can come back to at any time for quick help and more information.
Diabetes Frequently Asked Questions
Diabetes Education
Diabetes Educational Videos
A list of BMC's educational videos supporting diabetes patients.
Diabetes Technology Resources
Additional Information
Research Overview
Our Research Team
The diabetes research unit is composed of an interdisciplinary team engaged in ebasic, translational and clinical diabetes research. The department is engaged in a number of research studies, many sponsored by the pharmaceutical industry, which aim to help develop more effective treatment and management options for patients with diabetes. Research interests of our team include: diabetes types 1 and 2, atypical diabetes, MODY, inpatient diabetes management, and diabetes pathophysiology and the role of T cells. For more information, visit Boston University Chobanian & Avedisian School of Medicine’s Diabetes Research page.
Clinicians
Kathryn Fantasia, MD
Katie Modzelewski, MD
Devin Steenkamp, MBChB
Catherine Sullivan, MD
Basic Science Investigators
Jude Deeney, PhD
Hans Dooms, PhD
Research Support Staff
Asya Sullivan
Robert Seitter
Astrid Atakov Castillo
Kati Swift
Ongoing Studies (not currently enrolling)
None currently
Previous Studies
Please click on the study title for more information.
SWITCH PRO (Novo Nordisk)
This clinical trial is comparing the effect of insulin degludec and insulin glargine. Participants will first go through a 4-week screening and run-in period. If eligible to continue in the study, participants will be treated with insulin degludec (100 U/mL) and insulin glargine (100 U/mL) during two different periods each of 18 weeks duration. Both medicines are approved for use in humans and available on the market. In order to evaluate changes in blood sugar level over time while being treated with the two different insulins, participants will be asked to wear a small blood sugar sensor on the back of their upper arm 3 times during the study.
GAZELLE Trial
If you are an adult between ages 18 and 65 living with type 1 diabetes you may be eligible to take part in the GAZELLE clinical research trial. This trial will look at an investigational fast-acting insulin to see if it works as effectively as an existing fast-acting insulin already being used to treat diabetes. Trial-related medications, procedures, equipment and supplies will be provided at no cost; health insurance is not required to participate.
INSTRIDE 4
The INSTRIDE 4 Study is looking at the ways the investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes and to check how safe they are. All participants in this study receive the potentially long-acting investigational medication, in addition to an FDA-approved, rapid-acting insulin at mealtimes. Approximately 200 people are participating in this study internationally. The study is about 26 weeks (6 months) long.
PIONEER 2
Boston Medical Center was one of hundreds of sites to conduct the second phase 3a trial with oral semaglutide for treatment of adults with type 2 diabetes. Oral semaglutide is a new GLP-1 analogue taken once daily as a tablet. The 52-week, open label trial investigated the efficacy and safety of 14 mg oral semaglutide compared with 25 mg empagliflozin in 816 people with type 2 diabetes, inadequately controlled on metformin. The confirmatory endpoints were defined after 26 weeks of treatment. Read their full results announcement here.
Linagliptin Inpatient Trial
Full title: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients with Type 2 Diabetes. This study compared linagliptin (a once-daily diabetes pill) plus as-needed rapid insulin shots vs. long acting insulin glargine plus scheduled rapid insulin shots for the treatment of diabetes patients after they have surgery. Approximately 280 participants from 4 United States medical centers participated.
Linagliptin Outpatient Trial
Full title: The safety and efficacy of Linagliptin (Tradjenta®) therapy for an A1c directed post-discharge management algorithm of general surgery patients with type 2 diabetes: Only those individuals who completed the Linagliptin Inpatient Trial were invited to participate in this extended study. This study compared the effect of Linagliptin (diabetes pill) with insulin shots for the treatment of diabetes after participants left the hospital.
Technology usage among patients in the Center for Endocrinology, Diabetes, Nutrition and Weight Management
The purpose of this survey was to characterize the patient population of the BMC Endocrinology, Diabetes, Nutrition and Weight Management Clinic. We sought to dispel myths about technology access and usage among our patients. The survey was adapted from Pew Research Center’s technology questionnaire and their data. The survey contained questions about internet usage, device ownership, preferred communication methods, use of technology for health, social media usage, and optional demographic information.
Contact Us
Patients and visitors: If you are interested in hearing about studies that you may be able to participate in, please consider enrolling in the ENDO Registry. Alternatively, you may email EndoResearch@bmc.org or call 617-638-5906.
Are you interested in learning more about clinical research? Please visit our Clinical Research Basics page.